<DOC>
	<DOCNO>NCT00807365</DOCNO>
	<brief_summary>The purpose study evaluate effect naturally occur hormone , call Growth Hormone Releasing Hormone ( GHRH ) , muscle , bone fat tissue body . GHRH stimulate production growth hormone ( GH ) , regulate build many tissue body , include muscle bone . Many elderly people low level GH . The overall goal research determine effectiveness GHRH raise level GH improve body tissue . The purpose test measure body handle sugar , fat , protein . GH affect body 's use sugar , fat protein .</brief_summary>
	<brief_title>Six Month Treatment Growth Hormone Releasing Hormone ( GHRH ) Elderly</brief_title>
	<detailed_description>Growth hormone ( GH ) major anabolic hormone exerts important stimulatory effect protein synthesis . Many peripheral tissue effect GH mediate insulin-like growth factor I ( IGF-I ) , produce systemically liver locally tissue response GH stimulation . IGF-I turn regulate GH secretion negative feedback mechanism pituitary gland . Several investigator show age associated decrease spontaneous GH secretion IGF-I level . GH level decline 14 % decade puberty , , healthy 59-98 year old men , IGF-I level 2.5 percentile young men present 85 % . Reduction GH release age think associated increase somatostatin tone , decrease hypothalamic GHRH output , diminish response GHRH . The fact age accompanied decrease protein synthesis leading loss lean body mass ( LBM ) gain body fat suggest decrease GH secretion may contribute change . It hypothesize restoration GH level elderly level observe young individual may lead improvement body composition .</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Growth Hormone-Releasing Hormone</mesh_term>
	<mesh_term>Hormones , Hormone Substitutes , Hormone Antagonists</mesh_term>
	<criteria>Documentation low GH level assess fast IGF1 level &lt; 135ng/ml . Volunteers whose BMI normal range extreme obesity ( BMI 2540 kg/m2 ) . Diabetes . Known coronary artery disease . Liver , peptic inflammatory bowel disease . Renal hematologic disease . Hematocrit &lt; 30 % &gt; 50 % . Clinically significant prostate hypertrophy . Elevated PSA ( 4ng/ml ) . Prostate &amp; breast cancer . History malignancy &lt; 5 year basal cell skin . Chronic pulmonary disease systemic disorder . Use certain drug ( thiazide diuretic , betablockers , steroid ( except replacement dos ) , coumadin , androgen supplement ) . Peanut allergy . Gross physical impairment . Sleep apnea . Uncontrolled hypertension ( blood pressure &gt; 160/95 require two antihypertensive medication ) . A clinically worrisome mammogram woman . Exercise training ( &gt; 2x/wk 20 min level produce sweat ) last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Growth Hormone-Releasing Hormone</keyword>
	<keyword>Growth Hormone Insufficiency</keyword>
	<keyword>Aging</keyword>
	<keyword>Growth Hormone</keyword>
	<keyword>Physiological Effects Drugs</keyword>
	<keyword>Hormones , Hormone Substitutes , Hormone Antagonists</keyword>
	<keyword>Hormones</keyword>
</DOC>